Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO)

J Neural Transm (Vienna). 2002 Mar;109(3):251-65. doi: 10.1007/s007020200021.

Abstract

The specific activity and kinetic behaviour of semicarbazide-sensitive amine oxidase (EC 1.4.3.6; SSAO) towards benzylamine, in the rat heart, is affected by in vivo treatment with the non-selective monoamine oxidase (MAO) inhibitor tranylcypromine, but not by the selective MAO-A and -B inhibitors, clorgyline and lazabemide. SSAO activity was increased to 178% of control activity after 7 days of treatment with tranylcypromine. This increase appears to represent an increase in the limiting velocity (V(max)) for benzylamine oxidation with no significant change in the K(m) at that time-point. However, the K(m) for benzylamine oxidation was found to decrease in both controls and treated groups, in a time-dependent manner, during the treatment regime. These findings suggest a link between SSAO and cellular stress and may have importance in the context of the recent finding that tissue-SSAO is identical to a vascular adhesion protein (VAP1), involved in the process of inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amine Oxidase (Copper-Containing) / drug effects
  • Amine Oxidase (Copper-Containing) / metabolism*
  • Animals
  • Brain / drug effects
  • Brain / enzymology*
  • Clorgyline / pharmacology
  • Dopamine / metabolism
  • Female
  • Heart / drug effects
  • Heart / physiology*
  • Kinetics
  • Liver / drug effects
  • Liver / enzymology*
  • Monoamine Oxidase / drug effects
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Myocardium / enzymology*
  • Picolinic Acids / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Serotonin / metabolism
  • Subcellular Fractions / drug effects
  • Subcellular Fractions / metabolism
  • Tranylcypromine / pharmacology

Substances

  • Monoamine Oxidase Inhibitors
  • Picolinic Acids
  • Serotonin
  • Tranylcypromine
  • lazabemide
  • Amine Oxidase (Copper-Containing)
  • Monoamine Oxidase
  • Clorgyline
  • Dopamine